October 22, 2017 12:16 PM ET

Biotechnology

Company Overview of Reset Therapeutics, Inc.

Key Executives for Reset Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Ross Bersot CFA8 RelationshipsChief Executive Officer, President and Director--
Shu Kurosaki CPANo RelationshipsChief Financial Officer--
Dan Oppenheimer Ph.D.No RelationshipsChief Operating Officer--
Paul Humphries Ph.D.15 RelationshipsChief Scientific Officer--

Reset Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ross Bersot CFA 8 RelationshipsReset Therapeutics, Inc.--
Frederick B. Craves Ph.D. 132 RelationshipsBay City Capital LLC71
Steve A. Kay Ph.D., D.SC. 61 RelationshipsReset Therapeutics, Inc.--
Ron Evans Ph.D. 8 RelationshipsReset Therapeutics, Inc.--
Joseph S. Takahashi Ph.D. 25 RelationshipsHypnion, Inc.--
View All Board Members

Reset Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.5K
Bonus
244.7K
Total Short Term Compensation
487.0K
Total Value of Options
17.9M
Compensation as of Fiscal Year
Reset Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Verseon Corporation Appoints Robert W. Karr as Non-Executive Class II Director
October 20, 2017 6:00 AM ET
Neurocrine Biosciences, Inc. Announces Management Changes
October 19, 2017 9:26 PM ET
AveXis, Inc. Announces Management Changes
October 19, 2017 8:58 PM ET
Peregrine Pharmaceuticals, Inc. and Avid Bioservices, Inc. Appoint Mark R. Bamforth as an Independent Member of the Board of Directors
October 19, 2017 12:05 PM ET
Cellect Biotechnology Ltd. Announces Executive Changes
October 19, 2017 11:05 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Reset Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.